Sale of 14,051 shares at $36.57 per share.
Reporting Person Sullivan Mark · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 25, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001104659-26-112060 · filed 2026-09-29 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Definium Therapeutics, Inc. (DFTX)." Disclosed 2026-09-29. https://desqlong.com/cards/0001104659-26-112060-1 (retrieved 2026-09-30).